Cera: What? So What? Now What?

Maxwell, Lisa; Mazzone, Michael; Abercrombie, Stoney; Crownover, Brian; Hoekzema, Grant; Krug, Nathan; Mitchel, Karen; Schultz, Stephen; Shaffer, Todd; Tuggy, Michael

doi:10.1370/afm.1455

Cited by 1 publication

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Background on and details from other CERA surveys are published elsewhere. 48,49 Four e-mail reminders were sent. Some e-mails were undeliverable (n=80) and some providers opted out (n=68).…”

Section: Methodsmentioning

confidence: 99%

“…Our final question set (see Appendix) was reduced to accommodate multiple assessment domains in the CERA survey, as topic areas are generally limited to 10 questions 48 and underwent additional piloting by CERA leadership. 49 Question 1 assessed the inclusion criterion and question 2 was included to characterize the number of patients under the age of 18 seen in a practice.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Family Physicians’ Perceived Prevalence, Safety, and Screening for Cigarettes, Marijuana, and Electronic-Nicotine Delivery Systems (ENDS) Use during Pregnancy

et al. 2017

View full text Add to dashboard Cite

Objective Assess perceptions of prevalence, safety, and screening practices for cigarettes and secondhand smoke exposure (SHSe), marijuana (and synthetic marijuana), electronic nicotine delivery systems (ENDS; e.g., e-cigarettes), nicotine replacement therapy (NRT), and smoking-cessation medications during pregnancy, among primary care physicians (PCPs) providing obstetrical care. Methods A web-based, cross-sectional survey was e-mailed to 3750 US physicians (belonging to organizations within the Council of Academic Family Medicine Educational Research Alliance). Several research groups’ questions were included in the survey. Only physicians who reported providing “labor and delivery” obstetrical care responded to questions related to the study objectives. Results A total of 1248 physicians (of 3750) responded (33.3%) and 417 reported providing labor and delivery obstetrical care. Obstetrical providers (N=417) reported cigarette (54%), marijuana (49%), and ENDS use (24%) by “Some (6–25%)” pregnant women, with 37% endorsing that “Very Few (1–5%)” pregnant women used ENDS. Providers most often selected that very few pregnant women used NRT (45%), cessation medications (i.e., bupropion or varenicline; 37%), and synthetic marijuana (23%). Significant proportions chose “Don’t Know” for synthetic marijuana (58%) and ENDS (27%). Over 90% of the sample perceived that use of or exposure to cigarettes (99%), synthetic marijuana (99%), SHS (97%), marijuana (92%), or ENDS (91%) were unsafe, with the exception of NRT (44%). Providers most consistently screened for cigarette (85%) and marijuana use (63%), followed by SHSe in the home (48%), and ENDS (33%) and synthetic marijuana use (28%). Fewer than a quarter (18%) screened consistently for all substances and SHSe. A third (32%) reported laboratory testing for marijuana and 3% reported laboratory testing for smoking status. Conclusion This sample of PCPs providing obstetrical care within academic settings perceived cigarettes, marijuana, and ENDS use to be prevalent and unsafe during pregnancy. Opportunities for increased screening during pregnancy across these substances were apparent.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%